Sign in

CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
371957007
Phone
(781) 281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
  1. SC 13D/A Stake Beneficial Ownership Report
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 144/A Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. 4 Open-market sale 10% owner sold 822,680 shares at $0.75 ($617,010)
  12. SC 13D/A Stake Beneficial Ownership Report
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 8-K Event Regulation FD disclosure · Other events
  18. 4 Open-market sale 10% owner sold 209,400 shares at $3.00 ($628,200)
  19. SC 13D/A Stake Beneficial Ownership Report
  20. 144 Insider Sale of Securities

Page 9 of 18 · 353 filings